Taken together, our results suggest that loss of PR in ER+ breast cancer influences significantly the downstream tyrosine kinase signaling, possibly through multiple mechanisms and involving several kinases linked to the PI3K pathway. The gene discussed is PGR; the disease is breast cancer.